{"id":"CHEMBL1083385","canonicalSmiles":"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1.O=S(=O)(O)O","inchiKey":"FDEODCTUSIWGLK-RSAXXLAASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOPIDOGREL BISULFATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1771","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clopidogrel bisulfate","Plavix"],"synonyms":["Clopidogrel (as bisulfate)","Clopidogrel bisulfate","Clopidogrel bisulphate","Clopidogrel bms","Clopidogrel hydrogen sulfate","Clopidogrel hydrogen sulphate","Clopidogrel ratiopharm","Clopidogrel sulfate","Clopidogrel teva","Clopidogrel zentiva","Clopidogrel-bgr","Clopidogrel-bms","Isocover","Pidogrel","SR 25990C","SR-25990C"],"crossReferences":{"DailyMed":["clopidogrel%20bisulfate"],"PubChem":["144205123","170465231"],"chEBI":["3759"]},"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","HP_0002239","EFO_1000985","EFO_0000712","EFO_0001645","EFO_0000556","EFO_0008583","EFO_0000612","EFO_0005672","EFO_0004265"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 6 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1130","canonicalSmiles":"C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O","inchiKey":"ZWAOHEXOSAUJHY-ZIYNGMLESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXIFLURIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5'-Deoxy-5-Fluorouridine","Capecitabine related compound b","Doxifluridine","Flutron","Fulturon","Furtulon","NSC-758890","RO 219738","RO-219738"],"crossReferences":{"PubChem":["144204782","170465861","29215154","50106323","50106324","56320807","56322615","90341388"],"drugbank":["DB12947"],"chEBI":["31521"]},"linkedTargets":{"rows":["ENSG00000176890"],"count":1},"linkedDiseases":{"rows":["MONDO_0001056"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL119596","canonicalSmiles":"CCOCCO","inchiKey":"ZNQVEEAIQZEUHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-ETHOXYETHANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210351","17389338"],"Wikipedia":["2-Ethoxyethanol"],"drugbank":["DB02249"],"chEBI":["46788"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1197091","canonicalSmiles":"O=C(CC1NCCCC1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O","inchiKey":"LVASCWIMLIKXLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOFUGINONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HT-100","Halocur","Halofuginon","Halofuginone","Ht-100"],"childChemblIds":["CHEMBL1162013","CHEMBL559362"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1200478","canonicalSmiles":"CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1.Cl","inchiKey":"KNZADIMHVBBPOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DYCLONINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201217","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dyclone"],"synonyms":["Dyclocaine","Dyclonine HCl","Dyclonine hcl","Dyclonine hydrochloride","NSC-23018"],"crossReferences":{"DailyMed":["dyclonine%20hydrochloride"],"PubChem":["144204010","170464776","26748011","26748012","50107329","50107330","56422189","855952"],"chEBI":["4725"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200549","canonicalSmiles":"C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](OC(C)=O)[C@@H](N6CCCCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(=O)CC)CCCCC1.[Br-]","inchiKey":"LVQTUXZKLGXYIU-GWSNJHLMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RAPACURONIUM BROMIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201352","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Respiratory toxicity"],"year":2001},"tradeNames":["Raplon"],"synonyms":["ORG 9487","ORG-9487","Rapacuronium bromide"],"crossReferences":{"PubChem":["144206855"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999. It was withdrawn in United States  in 2001 due to Respiratory toxicity."}
{"id":"CHEMBL1200559","canonicalSmiles":"CC(O)C(=O)O","inchiKey":"JVTAAEKCZFNVCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACTIC ACID","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acidum lacticum","Dl- lactic acid","Dl-lactic acid","E 270","E-270","E270","FEMA NO. 2611","HIPURE 88","INS NO.270","INS-270","L-lactic acid or dl-lactic acid","Lactate","Lactic acid","Lactic acid, dl-","Lactic acid, unspecified form","Lactic acid,buffered","Lacticum acidum","Lurex","Milk acid","NSC-367919","Ordinary lactic acid","PURAC FCC 80","PURAC FCC 88","Racemic lactic acid","Tonsillosan"],"crossReferences":{"DailyMed":["lactic%20acid"],"PubChem":["144204600","144209653","144213921","170466852","17389538"],"drugbank":["DB04398"],"chEBI":["78320"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 2 investigational indications."}
{"id":"CHEMBL1200729","canonicalSmiles":"O=C([O-])CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1.[Na+]","inchiKey":"RPLOPBHEZLFENN-HTMVYDOJSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORAMPHENICOL SODIUM SUCCINATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201281","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chloramphenicol sodium succinate","Chloromyccetin Sod Succ","Chloromycetin","Mychel-s","Paraxin","Protophenicol"],"synonyms":["Chloramphenicol monosuccinate sodium salt","Chloramphenicol sodium succinate","Chloramphenicoli natrii succinas"],"crossReferences":{"DailyMed":["chloramphenicol%20sodium%20succinate"],"PubChem":["144207033","170465429"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 4 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200800","canonicalSmiles":"CC(=O)[O-].CC(=O)[O-].[Ca+2]","inchiKey":"VSGNNIFQASZAOI-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM ACETATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcium acetate","Eliphos","Everose","Phosex","Phoslo","Phoslo gelcaps","Phoslyra","Renacet"],"synonyms":["Acetic acid, calcium salt","Acetic acid, calcium salt (2:1)","Calcarea acetica","Calcium acetate","Calcium acetate anhydrous","Calcium acetate, anhydrous","E-263","E263","FEMA NO. 2228","INS NO.263","INS-263"],"crossReferences":{"DailyMed":["calcium%20acetate"],"DrugCentral":["4287"],"Wikipedia":["Calcium_acetate"],"drugbank":["DB00258"],"chEBI":["3310"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 approved indications."}
{"id":"CHEMBL1200976","canonicalSmiles":"CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O.Cl","inchiKey":"JVHPTYWUBOQMBP-RVFAQHLVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IDARUBICIN HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1117","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Idamycin","Idamycin pfs","Idarubicin hydrochloride","Idarubicin hydrochloride pfs","Zavedos"],"synonyms":["IMI 30","IMI-30","Idarubicin hcl","Idarubicin hydrochloride","NSC-256439"],"crossReferences":{"DailyMed":["idarubicin%20hydrochloride"],"PubChem":["144204787","170464627","49681632"]},"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["MONDO_0019457","EFO_0000182","MONDO_0044887","EFO_0000222","MONDO_0004643"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for acute myeloid leukemia and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201490","drugType":"Protein","blackBoxWarning":false,"name":"SERMORELIN ACETATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Geref"],"synonyms":["Groliberin","Sermorelin","Sermorelin acetate"],"crossReferences":{"Wikipedia":["Sermorelin"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1201539","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN PORK","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iletin i","Insulin","Regular insulin"],"synonyms":["Insulin porcine","Insulin porcine insulin","Insulin pork"],"crossReferences":{"DrugCentral":["5191"]},"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0004593","EFO_0002614","MONDO_0005147","HP_0003074","HP_0011015","EFO_0001645","EFO_0003884","EFO_1000897","EFO_0000400","MONDO_0005148","EFO_0005672","EFO_0000311"],"count":12},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and has 5 investigational indications."}
{"id":"CHEMBL1201613","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN GLULISINE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apidra","Apidra solostar","Ins apidra","Ins apidra opticlik","Ins apidra optiset","Ins apidra solostar"],"synonyms":["Glulisine apidra","HMR 1964","HMR-1964","HMR1964","Insulin Glulisine Recombinant","Insulin glulisine","Insulin glulisine recombinant","Insulin, glulisine, human","Insulin,glulisine,human"],"crossReferences":{"DailyMed":["insulin%20glulisine%20recombinant"],"DrugCentral":["5057"]},"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","MONDO_0004975","EFO_0001064","EFO_0000612","MONDO_0005148","EFO_0000400"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for diabetes mellitus and has 5 investigational indications."}
{"id":"CHEMBL1201760","canonicalSmiles":"N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1","inchiKey":"QFFGVLORLPOAEC-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BESIFLOXACIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Besifloxacin","ISV-403"],"crossReferences":{"DailyMed":["besifloxacin%20hydrochloride"],"Wikipedia":["Besifloxacin"],"drugbank":["DB06771"]},"childChemblIds":["CHEMBL1201761"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for eye infection and bacterial conjunctivitis and has 2 investigational indications."}
{"id":"CHEMBL1204498","canonicalSmiles":"O=C(Nc1ccc(Oc2ncccn2)cc1C(=O)O)c1ccc(Cl)cc1Cl","inchiKey":"VNDRRWBKNSHALL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1204498","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08402"]},"childChemblIds":["CHEMBL118206"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1208642","canonicalSmiles":"O=S(=O)(O)S","inchiKey":"DHCDFWKWKRSZHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOSULFURIC ACID","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Thiosulfate"],"crossReferences":{"DailyMed":["sodium%20thiosulfate"],"drugbank":["DB09499"],"chEBI":["29279"]},"childChemblIds":["CHEMBL3753202","CHEMBL2251960","CHEMBL2096650"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 12 investigational indications."}
{"id":"CHEMBL1235255","canonicalSmiles":"COCCOCCOCCOC","inchiKey":"YFNKIDBQEZZDLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235255","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26757434"],"drugbank":["DB02078"],"chEBI":["44842"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235647","canonicalSmiles":"O=C(O)CCCC[C@@H](S)CCS","inchiKey":"IZFHEQBZOYJLPK-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROLIPOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6,8-Dimercaptooctanoic Acid","Dihydrolipoic Acid","Dihydrolipoicacid"],"crossReferences":{"drugbank":["DB03760"],"chEBI":["45230"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235738","canonicalSmiles":"C#CCN[C@H]1CCc2ccccc21","inchiKey":"RUOKEQAAGRXIBM-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZILECT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03894"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1245","canonicalSmiles":"CC1(C)C2CCC1(CS(=O)(=O)[O-])C(=O)C2.O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1","inchiKey":"HALWUDBBYKMYPW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHAPHAN CAMSYLATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201329","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arfonad"],"synonyms":["NU-2222","Trimetaphan camsilate","Trimetaphan camsylate","Trimethaphan Camsylate","Trimethaphan camphorsulfonate","Trimethaphan camsylate"],"crossReferences":{"Wikipedia":["Trimetaphan_camsilate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1287853","canonicalSmiles":"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1","inchiKey":"JOOXLOJCABQBSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEDRATINIB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fedratinib","SAR-302503","SAR302503","Sar-302503","TG-101348","TG101348"],"crossReferences":{"DailyMed":["fedratinib%20hydrochloride"],"drugbank":["DB12500"]},"childChemblIds":["CHEMBL4297216"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000122025"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0002430","EFO_0003086","EFO_0004251","MONDO_0044903","EFO_0001421","EFO_1000179","EFO_0002429","HP_0011974"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 5 investigational indications."}
{"id":"CHEMBL1321","canonicalSmiles":"CNNCc1ccc(C(=O)NC(C)C)cc1","inchiKey":"CPTBDICYNRMXFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCARBAZINE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Matulane","Procarbacine","Procarbazine","RO-4-6467","RO-4-6467 FREE BASE"],"crossReferences":{"DailyMed":["procarbazine%20hydrochloride"],"PubChem":["11112335","144212055","174007426"],"Wikipedia":["Procarbazine"],"drugbank":["DB01168"],"chEBI":["71417"]},"childChemblIds":["CHEMBL1200410"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and is indicated for neoplasm and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1370561","canonicalSmiles":"Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN","inchiKey":"FQPFAHBPWDRTLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOPHYLLINE","yearOfFirstApproval":1940,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL190","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aminophyllin","Aminophylline","Aminophylline In Sodium Chloride","Aminophylline dye free","Ammophyllin","Amnivent-225 sr","Amnivent-350 sr","Peterphyllin","Phyllocontin","Somophyllin","Somophyllin-df","Truphylline"],"synonyms":["Aminophylline","Aminophyllinum","Cardophyllin","Linampheta","NSC-7919","Syntophyllin","Theophyllamine","Theophylline ethylenediamine","Theophylline-ethylenediamine"],"crossReferences":{"DailyMed":["aminophylline"],"PubChem":["11111990","11111991","50105733","85231291"],"drugbank":["DB01223"]},"linkedTargets":{"rows":["ENSG00000152270","ENSG00000282608","ENSG00000170425","ENSG00000065989","ENSG00000105650","ENSG00000128271","ENSG00000163485","ENSG00000113448","ENSG00000172572","ENSG00000184588"],"count":10},"linkedDiseases":{"rows":["HP_0006536","EFO_0001361","HP_0001919","EFO_0003884","MONDO_0004979","EFO_1000782","EFO_0003917","HP_0002315","EFO_0009492","MONDO_0001187"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1940 and is indicated for airway obstruction and asthma and has 7 investigational indications."}
{"id":"CHEMBL1481","canonicalSmiles":"CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O","inchiKey":"WIGIZIANZCJQQY-RUCARUNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLIMEPIRIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amaryl","Glimepiride","Niddaryl"],"synonyms":["Amaryl","Glimepiride","HOE 490","HOE-490","NSC-759809"],"crossReferences":{"DailyMed":["glimepiride"],"PubChem":["144204264","170464966","49648856"],"Wikipedia":["Glimepiride"],"drugbank":["DB00222"],"chEBI":["5383"]},"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0003914","HP_0003124","EFO_0003095","Orphanet_552","EFO_0001645","MONDO_0005148","EFO_0000400","HP_0012594","EFO_0000537"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL1483877","canonicalSmiles":"CCOc1ccccc1C(N)=O","inchiKey":"SBNKFTQSBPKMBZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHENZAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etenzamide","Ethenzamide","J3.352I","NSC-28787","O-ethoxybenzamide"],"crossReferences":{"PubChem":["144204707","144207223","170465775","17389894","87334323"],"drugbank":["DB13544"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1489662","canonicalSmiles":"O=C(Cc1ccc(-c2ccccc2)cc1)Nc1ccccn1","inchiKey":"PWHROYKAGRUWDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFENPIRAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Difenax","Difenpiramide","Diphenpyramide","NSC-305337","Z-876"],"crossReferences":{"PubChem":["49672633"],"drugbank":["DB13371"],"chEBI":["76130"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1528839","canonicalSmiles":"Cl.N=C(N)NC(=N)NCCc1ccccc1","inchiKey":"YSUCWSWKRIOILX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENFORMIN HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL170988","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," Germany"," France"],"classes":["Metabolism toxicity"],"year":1977},"tradeNames":["Dibotin s.r."],"synonyms":["Debei","NSC-23100","Phenformin hcl","Phenformin hydrochloride"],"crossReferences":{"PubChem":["144204035","144204736","144209395","144213321","170466230","17389768","26757813","56463711","855734"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States,  Germany and  France initially in 1977 due to Metabolism toxicity."}
{"id":"CHEMBL1607","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1.Cl","inchiKey":"DGHHQBMTXTWTJV-BQAIUKQQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOPOTECAN HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL84","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hycamptin","Hycamtin","Topotecan","Topotecan hydrochloride"],"synonyms":["Evotopin","NSC-759263","Nogitecan hydrochloride","SK&F S-104864-A","SK&F-S-104864A","SK-S-104864-A","Topotecan (as hydrochloride)","Topotecan actavis","Topotecan hcl","Topotecan hospira","Topotecan hydrochloride","Topotecan teva"],"crossReferences":{"DailyMed":["topotecan%20hydrochloride"],"PubChem":["144205031","170465137","26749084","4254372","49681835","50107520","580652"]},"linkedTargets":{"rows":["ENSG00000184428"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0001075","EFO_0000681","MONDO_0000956","EFO_1000657","MONDO_0004222","EFO_0005952","EFO_0005561","EFO_0000565","MONDO_0002974","EFO_0000389","MONDO_0008903","EFO_1000251","EFO_1001331","EFO_0002918","Orphanet_654","EFO_0001416","EFO_0000198","MONDO_0037745","EFO_0003893","EFO_0000466","MONDO_0018271","EFO_0000220","EFO_1000823","MONDO_0008170","EFO_0000502","MONDO_0008315","Orphanet_357034","Orphanet_398934","EFO_0000630","EFO_0001061","MONDO_0100096","EFO_0003851","EFO_1001100","EFO_0008524","EFO_0002428","EFO_0000574","MONDO_0002380","EFO_0001378","EFO_1000172","MONDO_0100342","MONDO_0015686","EFO_1001465","MONDO_0007254","Orphanet_790","EFO_0002087","MONDO_0021063","MONDO_0002087","EFO_0000305","EFO_1000357","EFO_0007362","MONDO_0002158","EFO_1000043","MONDO_0012825","EFO_0000326","EFO_0002499","EFO_1001963","EFO_0002617","EFO_1000158","EFO_0000616","EFO_0008498","EFO_1001042","EFO_0000222","EFO_0000313","MONDO_0007576","EFO_0002501","EFO_0000613","EFO_0000621","EFO_0003060","EFO_0000311","EFO_0000174","MONDO_0011962","EFO_0000702","EFO_1002008","MONDO_0019004","EFO_1000895","EFO_0003833","EFO_0000691","EFO_0000519","MONDO_0024880"],"count":80},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 7 approved and 55 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1702228","canonicalSmiles":"CCOC(=O)c1cccc(N)c1","inchiKey":"ZMCBYSBVJIMENC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1702228","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217778"],"drugbank":["DB11552"],"chEBI":["81494"]},"childChemblIds":["CHEMBL3184210"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742988","drugType":"Protein","blackBoxWarning":false,"name":"BAMINERCEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BG 9924","BG-9924","BG9924","Baminercept","Baminercept alfa","TT-47"],"linkedTargets":{"rows":["ENSG00000226979","ENSG00000125735","ENSG00000227507"],"count":3},"linkedDiseases":{"rows":["EFO_0000685","EFO_0004220","EFO_0008522","EFO_0000699"],"count":4},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743045","drugType":"Antibody","blackBoxWarning":false,"name":"NAPTUMOMAB ESTAFENATOX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABR-217620","ANYARA","ANYARA TTS CD3","Naptumomab estafenatox","TTS CD3","TTS-CD3"],"linkedTargets":{"rows":["ENSG00000146242"],"count":1},"linkedDiseases":{"rows":["EFO_0000681","EFO_0003060"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1774461","canonicalSmiles":"CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1","inchiKey":"YNDIAUKFXKEXSV-CRYLGTRXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORBETAPIR F 18","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1908919","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amyvid"],"synonyms":["(18F)AV-45","18F-AV-45","18f-av45","AV-45 F-18","Av45 f-18","Florbetapir (18f)","Florbetapir f 18","Florbetapir f-18","Florbetapir(18-f)","Florbetapir, f-18"],"crossReferences":{"DailyMed":["florbetapir%20f-18"],"drugbank":["DB09149"],"chEBI":["66880"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for alzheimer disease and cognitive impairment."}
{"id":"CHEMBL1909324","canonicalSmiles":"COc1cc(Br)c(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)cc1OC","inchiKey":"DDHUTBKXLWCZCO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINAVERIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pinaverium","Pinaverium cation","Pinaverium ion"],"crossReferences":{"drugbank":["DB09090"]},"childChemblIds":["CHEMBL1909298"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL194378","canonicalSmiles":"CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12","inchiKey":"QVDSEJDULKLHCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSILOCYBINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CY 39","CY-39","Indocybin","Psilocybin","Psilocybine","Teonanacatl"],"crossReferences":{"PubChem":["144206451"],"Wikipedia":["Psilocybin"],"drugbank":["DB11664"],"chEBI":["8614"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL199544","canonicalSmiles":"O=C(O)c1ccc(-c2ccc([N+](=O)[O-])cc2Cl)o1","inchiKey":"HDIHNBCCQWMVBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL199544","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07305"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2008565","canonicalSmiles":"N=C(N)NCC1CCCCCCN1","inchiKey":"ZCVAIGPGEINFCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANAZODINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guanazodine"],"crossReferences":{"drugbank":["DB13604"]},"childChemblIds":["CHEMBL2000371"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2087361","canonicalSmiles":"C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1","inchiKey":"QQLKULDARVNMAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICOTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BPI-2009H","Bpi-2009","Icotinib"],"crossReferences":{"drugbank":["DB11737"]},"childChemblIds":["CHEMBL4297665"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0005922","EFO_1000849","MONDO_0021117","EFO_0000571","MONDO_0007254","MONDO_0007576","EFO_0000313","EFO_0004252","EFO_0000708","EFO_0003060","EFO_0000311","MONDO_0008903","EFO_0000233","EFO_0000676"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL209821","canonicalSmiles":"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1","inchiKey":"SPWZXWDPAWDKQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALUZOTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naluzotan","PRX-00023"],"crossReferences":{"drugbank":["DB05562"]},"childChemblIds":["CHEMBL2105647"],"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0005230","EFO_0000773"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2103738","canonicalSmiles":"O.O.O.O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]","inchiKey":"HXGWMCJZLNWEBC-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":true,"name":"LITHIUM CITRATE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201170","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Li-liquid","Litarex","Lithium citrate","Lithonate"],"synonyms":["Lithium (as citrate)","Lithium citrate","Lithonate s","NSC-758700"],"crossReferences":{"DrugCentral":["4512"],"chEBI":["64754"]},"linkedTargets":{"rows":["ENSG00000082701","ENSG00000105723","ENSG00000133731"],"count":3},"linkedDiseases":{"rows":["EFO_0009963","EFO_0005407"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for psychosis and bipolar i disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104402","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O","inchiKey":"DDPFHDCZUJFNAT-PZPWKVFESA-N","drugType":"Protein","blackBoxWarning":false,"name":"ELCATONIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elcatonin"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104700","canonicalSmiles":"Cc1ccc(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1","inchiKey":"AGAHNABIDCTLHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOPERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylperidol","Moperone","Moperone hydrochloride","R 1658"],"crossReferences":{"drugbank":["DB13554"]},"childChemblIds":["CHEMBL2357018"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104984","canonicalSmiles":"Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)cc3F)nc2C)ccc1OC(C)(C)C(=O)O","inchiKey":"ZUGQWAYOWCBWGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODELGLITAZAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-677954","GW677954","Sodelglitazar"],"linkedTargets":{"rows":["ENSG00000112033","ENSG00000186951","ENSG00000132170"],"count":3},"linkedDiseases":{"rows":["EFO_0000195","MONDO_0005148"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105399","canonicalSmiles":"Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C","inchiKey":"CYFLXLSBHQBMFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMOXOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-683535","Sulfamoxole","Sulphamoxole"],"crossReferences":{"drugbank":["DB08798"],"chEBI":["55548"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106111","canonicalSmiles":"CC(O)C(=O)[O-].CC(O)C(=O)[O-].[Ca+2]","inchiKey":"MKJXYGKVIBWPFZ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM LACTATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prequist powder"],"synonyms":["Calcium (as lactate)","Calcium lactate","Calcium lactate anhydrous","Calcium lactate, anhydrous","Calphosan","E-327","INS NO.327","INS-327","INS-327-","Lactic acid, calcium salt (2:1)"],"crossReferences":{"DrugCentral":["4383"],"PubChem":["144208576","144213213"],"drugbank":["DB13231"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2109606","drugType":"Antibody","blackBoxWarning":false,"name":"GSK-1070806","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-1070806","Gsk-1070806"],"linkedTargets":{"rows":["ENSG00000150782"],"count":1},"linkedDiseases":{"rows":["EFO_0003780","EFO_0000274","EFO_0000400","EFO_0000384","EFO_0003767"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2110948","canonicalSmiles":"C[N+]1(C)CCCC1COC(=O)C(O)(c1ccccc1)c1ccccc1","inchiKey":"CQRKVVAGMJJJSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POLDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Poldine"],"crossReferences":{"drugbank":["DB13507"]},"childChemblIds":["CHEMBL2106739"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL2111099","canonicalSmiles":"COc1ccc(C(C)(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1","inchiKey":"OMPCVMLFFSQFIX-CONSDPRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAROPITANT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Maropitant"],"crossReferences":{"drugbank":["DB11427"]},"childChemblIds":["CHEMBL2107353"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221046","canonicalSmiles":"CC(C)C[C@@]1(C(=O)O)C[C@H](C(=O)O)[C@H](c2nccs2)N1C(=O)c1ccc(C(C)(C)C)cc1","inchiKey":"SWYJAQWTBADJTB-RHGYRFJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL221046","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07199"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL222913","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSC(=O)c3ccco3)CS[C@H]12)c1csc(N)n1","inchiKey":"ZBHXIWJRIFEVQY-IHMPYVIRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTIOFUR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ceftiofur","Ceftiofur crystalline free acid","Naxcel"],"crossReferences":{"PubChem":["144206093"],"Wikipedia":["Ceftiofur"],"drugbank":["DB11485"]},"childChemblIds":["CHEMBL2105998","CHEMBL2106486"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL228369","canonicalSmiles":"CCN(CC)C(=O)c1c(NC(=O)c2cccs2)sc2c1CCCC2","inchiKey":"NZTHBWHANVWSRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL228369","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08032"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2304327","canonicalSmiles":"CCC(C)CCCCC(=O)N(CS(=O)(=O)O)[C@@H](CCNCS(=O)(=O)O)C(=O)N[C@@H](CN[C@@H](CCNCS(=O)(=O)O)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CCNCS(=O)(=O)O)NC(=O)[C@H](CCNCS(=O)(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS(=O)(=O)O)NC1=O)[C@@H](C)O","inchiKey":"RRDRHWJDBOGQHN-JWCTVYNTSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"COLISTIMETHATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Colistimethate","Colistin methanesulfonic acid","Colistin sulfomethate","Colistinmethanesulfonic acid"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL232943","canonicalSmiles":"COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1","inchiKey":"WZZIQHIQMWJNLU-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK0686","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0686","MK0686","Mk0686"],"crossReferences":{"drugbank":["DB12563"]},"linkedTargets":{"rows":["ENSG00000100739"],"count":1},"linkedDiseases":{"rows":["MONDO_0041052","EFO_0003843","MONDO_0005178"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2356023","canonicalSmiles":"CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3\\C[C@@H](O)CC[C@@H]3C)CCC[C@@]21C","inchiKey":"ILYCWAKSDCYMBB-OPCMSESCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROTACHYSTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A.t. 10","Dihydral","Dygratyl","Hytakerol","Tachyrol"],"synonyms":["Dichysterol","Dihydrotachysterol","Dihydrotachysterol 2","Dihydrotachysterol2","Tachysterol dihydro derivative","Vitamin d1"],"crossReferences":{"PubChem":["144205894"],"drugbank":["DB01070"],"chEBI":["4591"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL238804","canonicalSmiles":"CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1","inchiKey":"QXWZQTURMXZVHJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELEXIPAG","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uptravi"],"synonyms":["ACT-293987","NS-304","Selexipag"],"crossReferences":{"DailyMed":["selexipag"],"drugbank":["DB11362"]},"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","Orphanet_275766","Orphanet_422","HP_0004419"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 4 approved indications."}
{"id":"CHEMBL24072","canonicalSmiles":"CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1","inchiKey":"IFFPICMESYHZPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRENYLAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," Germany"," France"," Malaysia"],"classes":["Cardiotoxicity"],"year":1988},"tradeNames":[],"synonyms":["B-436","Prenylamine","Prenylamine lactate"],"crossReferences":{"Wikipedia":["Prenylamine"],"drugbank":["DB04825"]},"childChemblIds":["CHEMBL1367944"],"linkedTargets":{"rows":["ENSG00000183873","ENSG00000198668"],"count":2},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease. It was withdrawn in United Kingdom,  Germany,  France and  Malaysia initially in 1988 due to Cardiotoxicity."}
{"id":"CHEMBL255044","canonicalSmiles":"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N","inchiKey":"JUUFBMODXQKSTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPIRTINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flupirtine","Flupirtinte","W-2964"],"crossReferences":{"PubChem":["11111201","124880149","174006272","90341043"],"Wikipedia":["Flupirtine"],"drugbank":["DB06623"]},"childChemblIds":["CHEMBL1256752","CHEMBL543869"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL255750","canonicalSmiles":"CCc1cc(CCN)ccc1O","inchiKey":"LDAFQVRTSOETPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL255750","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07346"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261713","canonicalSmiles":"O=C(NO)[C@@H](Cc1ccc2ccccc2c1)NS(=O)(=O)c1ccc2ccccc2c1","inchiKey":"MMOUXLMPQFMDRD-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BB-78485","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BB-78485"],"crossReferences":{"drugbank":["DB07861"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL264702","canonicalSmiles":"O=C(O)c1ccc2c(c1)C(=O)N([C@H](Cc1ccc(O)cc1)C(=O)O)C2=O","inchiKey":"QISJEFYTLZTWIQ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL264702","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26740843"],"drugbank":["DB07663"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL318153","canonicalSmiles":"CCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O","inchiKey":"XACKNLSZYYIACO-DJLDLDEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDOXUDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EDU","EUDR","Edoxudine","NSC-758405","ORF 15817","ORF-15817","RWJ 15817","RWJ-15817"],"crossReferences":{"PubChem":["144204943","56423684","855823"],"drugbank":["DB13421"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3188576","canonicalSmiles":"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"CZWJCQXZZJHHRH-YCRXJPFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROSTREPTOMYCIN SULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1950576","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Neurotoxicity"," Psychiatric toxicity"],"year":1970},"tradeNames":[],"synonyms":["Dihydrostreptomycin sulfate","Dihydrostreptomycin sulphate","NSC-756739"],"crossReferences":{"PubChem":["144204862"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1970 due to Neurotoxicity and  Psychiatric toxicity."}
{"id":"CHEMBL3353541","canonicalSmiles":"C[C@]1(C(=O)N(CCCC(=O)O)Cc2cccc(Cl)c2)CCN1C(=O)c1csc2ccccc12","inchiKey":"MPMKMQHJHDHPBE-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLPG-0974","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GLPG-0974","GLPG0974","Glpg-0974","Glpg0974"],"crossReferences":{"drugbank":["DB15406"]},"linkedTargets":{"rows":["ENSG00000126262"],"count":1},"linkedDiseases":{"rows":["EFO_0000729"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL340032","canonicalSmiles":"CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O","inchiKey":"ZHUJMSMQIPIPTF-IBURTVSXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DADLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DADLE"],"crossReferences":{"drugbank":["DB08856"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545035","canonicalSmiles":"COCCCN1CC[C@@H](CNC(=O)c2cc(Cl)c(N)c3c2OC(C)(C)C3)[C@H](O)C1","inchiKey":"FOUUNSGQVBGYQM-SUMWQHHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REVEXEPRIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-revexepride","R-149402","R149402","Revexepride","SPD-557","SPD557","Ssp-002358"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["EFO_0003948"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545146","drugType":"Small molecule","blackBoxWarning":false,"name":"SRX251","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Srx251"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545217","drugType":"Small molecule","blackBoxWarning":false,"name":"NS-018","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ilginatinib","NS-018","Ns-018"],"linkedTargets":{"rows":["ENSG00000096968"],"count":1},"linkedDiseases":{"rows":["EFO_0002430","MONDO_0044903"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707204","canonicalSmiles":"CC[N+](C)(CC)CCOC(c1ccccc1)c1ccccc1.[I-]","inchiKey":"HKOZYKMXXBHEHT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"(2-BENZHYDRYLOXYETHYL)DIETHYL-METHYLAMMONIUM IODIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3707205","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(2-benzhydryloxyethyl)diethyl-methylammonium iodide"],"crossReferences":{"drugbank":["DB13769"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707318","drugType":"Small molecule","blackBoxWarning":false,"name":"GRC-17536","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Grc-17536"],"linkedTargets":{"rows":["ENSG00000104321"],"count":1},"linkedDiseases":{"rows":["EFO_1000783"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL389507","canonicalSmiles":"O=C(Nc1ccc(O)cc1)c1ccccc1O","inchiKey":"LGCMKPRGGJRYGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSALMID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-1718","NSC-93960","Osalmid"],"crossReferences":{"PubChem":["144205467","29216264"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3911164","canonicalSmiles":"Cc1cccc2c1NC(=O)[C@@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)N=C2c1cccc(F)c1","inchiKey":"SRJNRAQUSAVENA-GSHUGGBRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986115","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms 986115","Bms-986115"],"crossReferences":{"drugbank":["DB13126"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3935857","canonicalSmiles":"Nc1nc2cc(-c3ccc4ncc(C(=O)N5CCOCC5)n4c3)ccc2o1","inchiKey":"BLGWHBSBBJNKJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERABELISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-PC-0DB6FL","INK1117","MLN-1117","MLN1117","Mln-1117","Serabelisib","TAK-117","Tak-117"],"crossReferences":{"drugbank":["DB14935"]},"linkedTargets":{"rows":["ENSG00000121879"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000681","EFO_0004230","EFO_0003060","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3963485","canonicalSmiles":"COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1","inchiKey":"HNLRRJSKGXOYNO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROGARATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1163877","Bay-1163877","Rogaratinib"],"crossReferences":{"drugbank":["DB15078"]},"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0008528","EFO_0006544","EFO_0003060","MONDO_0001187","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL398891","canonicalSmiles":"CCOc1ccc(F)c(CCNC(=S)Nc2ccc(Br)cn2)c1Cl","inchiKey":"DTHZUSMREBJMBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOUREA, N-(5-BROMO-2-PYRIDINYL)-N'-(2-(2-CHLORO-3-ETHOXY-6-FLUOROPHENYL)ETHYL)-","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PT-112","Thiourea, n-(5-bromo-2-pyridinyl)-n'-(2-(2-chloro-3-ethoxy-6-fluorophenyl)ethyl)-"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3989768","canonicalSmiles":"CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13.O.O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"UMZNDVASJKIQCB-SODJFYQGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVORPHANOL TARTRATE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL592","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dromoran","Levo-dromoran","Levorphanol tartrate"],"synonyms":["Levorphanol tartrate","Levorphanol tartrate anhydrous","Levorphanol tartrate dihydrate","NSC-91012"],"crossReferences":{"DailyMed":["levorphanol%20tartrate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3991443","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS GLUCONATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3833303"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anemia (phenotype)."}
{"id":"CHEMBL400754","canonicalSmiles":"CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1","inchiKey":"NNPCFFIJVKYGHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL400754","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07167"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL405730","canonicalSmiles":"Cc1cn([C@H]2C=C[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"LXCAIISEDMYORY-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL405730","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02569"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297294","canonicalSmiles":"O=C(Nc1cnccc1Cl)N1CCN(Cc2ccc3c(c2)OC(F)(F)O3)CC1","inchiKey":"YWGYNGCRVZLMCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-42165279","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-42165279"],"crossReferences":{"drugbank":["DB15173"]},"linkedTargets":{"rows":["ENSG00000117480"],"count":1},"linkedDiseases":{"rows":["EFO_0003756","EFO_1001908"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297338","canonicalSmiles":"Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2[18F])c(=O)[nH]c1=O","inchiKey":"GBBJCSTXCAQSSJ-MSYRQUNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-METHYL-2'-FLUOROARAURACIL F-18","maximumClinicalTrialPhase":1,"parentId":"CHEMBL475717","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["18f-fmau","5-methyl-2'-fluoroarauracil f-18","D-fmau f-18","Fmau f-18","J2.616.188F"],"crossReferences":{"drugbank":["DB14913"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297353","canonicalSmiles":"CCCS(=O)(=O)N1CCN(Cc2ccc(NC(=O)c3ccc(-c4cc(NC(=O)C5CC5)ccc4OC(F)(F)F)cc3)cc2)CC1","inchiKey":"MAQDQJWCSSCURR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-7295","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD7295","Azd 7295","Azd-7295","Azd7295"],"crossReferences":{"drugbank":["DB12724"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297497","canonicalSmiles":"NCc1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2CCCC(F)(F)F","inchiKey":"JOPCJJSYRPUEDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SISUNATOVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RV-521","RV521","Rv-521","Rv521","Sisunatovir"],"crossReferences":{"drugbank":["DB15674"]},"childChemblIds":["CHEMBL4802253"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297604","canonicalSmiles":"O=C(O)c1ccc(CN2C[C@@H]3C[C@H]2CN3Cc2ccc(Oc3ccc(-c4ncco4)cc3)cc2)cc1","inchiKey":"GERJIEKMNDGSCS-DQEYMECFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEBILUSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acebilustat","CTX-4430","Ctx-4430","EP-501"],"crossReferences":{"drugbank":["DB15385"]},"linkedTargets":{"rows":["ENSG00000111144"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","Orphanet_586","Orphanet_79383","EFO_0003894"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297809","drugType":"Antibody","blackBoxWarning":false,"name":"ELRANATAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elranatamab","PF-06863135","Pf-06863135","RN-613","RN613"],"linkedTargets":{"rows":["ENSG00000167286","ENSG00000048462","ENSG00000198851","ENSG00000160654"],"count":4},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297860","drugType":"Antibody","blackBoxWarning":false,"name":"TILAVONEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-8E12","Abbv-8e12","Tilavonemab"],"linkedTargets":{"rows":["ENSG00000186868"],"count":1},"linkedDiseases":{"rows":["Orphanet_683","MONDO_0004975"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297925","drugType":"Enzyme","blackBoxWarning":false,"name":"EXEBACASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CF-301","CF301","Cf-301","Exebacase"],"description":"Enzyme drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL44354","canonicalSmiles":"CC(C)(O/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)O","inchiKey":"ORFOPKXBNMVMKC-DWVKKRMSSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CEFTAZIDIME","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceftazidime","Ceptaz","Fortam","Fortaz","Fortum","Kefazim","Pentacef","Tazicef","Tazidime"],"synonyms":["Ceftazidime","Ceftazidime (arginine formulation)","Ceftazidime anhydrous","Ceftazidime hydrate","Ceftazidime pentahydrate","Ceptaz","Fortaz","GR 20263","GR-20263","J01DD07","LY 139381","LY-139381","NSC-759260","Pentacef","Tazicef","Tazidime"],"crossReferences":{"DailyMed":["ceftazidime"],"drugbank":["DB00438"],"chEBI":["3508"]},"childChemblIds":["CHEMBL3186392","CHEMBL1200768"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 7 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL444172","canonicalSmiles":"O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1","inchiKey":"IHOVFYSQUDPMCN-DBEBIPAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOSUQUIDAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zosuquidar"],"crossReferences":{"Wikipedia":["Zosuquidar"],"drugbank":["DB06191"]},"childChemblIds":["CHEMBL2074689"],"linkedTargets":{"rows":["ENSG00000085563"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000198"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594280","canonicalSmiles":"O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H]1CC[C@H](CNC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)CC1)C(=O)O)C(=O)O","inchiKey":"JBHPLHATEXGMQR-LFWIOBPJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIPIVOTIDE TETRAXETAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DKFZ-PSMA-617","PSMA-617","PSMA617","Vipivotide tetraxetan"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594320","drugType":"Enzyme","blackBoxWarning":false,"name":"AVALGLUCOSIDASE ALFA","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nexviazyme"],"synonyms":["Avalglucosidase alfa","Avalglucosidase alfa-ngpt","GZ-402666","GZ402666","Gz402666","neoGAA"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for glycogen storage disease due to acid maltase deficiency and has 1 investigational indication."}
{"id":"CHEMBL4594582","drugType":"Unknown","blackBoxWarning":false,"name":"NZV-930","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NZV-930","NZV930","Nzv-930","Nzv930","SRF-373"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802189","drugType":"Unknown","blackBoxWarning":false,"name":"BAVDEGALUTAMIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARV-110","Arv-110","Bavdegalutamide"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802200","drugType":"Antibody","blackBoxWarning":false,"name":"MUPADOLIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPI-006","CPX-006","Cpi-006","Mupadolimab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL486921","canonicalSmiles":"O=C1OCC/C1=C\\Nc1ccccc1","inchiKey":"BKXNPYSVWOVZGX-CMDGGOBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL486921","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07317"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL487","canonicalSmiles":"CC/C(=C(/c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1","inchiKey":"ZQZFYGIXNQKOAV-OCEACIFDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROLOXIFENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-hydroxytamoxifen","Droloxifene","E-Droloxifene","FK-435","Fk-435","K-060","K-21060E","K060","K060E"],"crossReferences":{"chEBI":["34731"]},"childChemblIds":["CHEMBL2105786"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL490961","canonicalSmiles":"CNc1ccc(Sc2nncn2C)cc1C(=O)Nc1nc(C)cs1","inchiKey":"XRJAKERBMMBUGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL490961","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08118"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL494397","canonicalSmiles":"C/N=C(\\N)N(C)C(=N)N.Cl","inchiKey":"GWWIHNWMWIJWRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METFORMIN XR","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1187231","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metformin xr"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL495597","canonicalSmiles":"CCN(CC)C(=O)Cc1cccc(NS(=O)(=O)c2cccc(Cl)c2C)n1","inchiKey":"JNWQLOFSMUGRNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL495597","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07056"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL499017","canonicalSmiles":"O=S(=O)(Oc1ccc(Cl)cc1)c1ccc(Cl)cc1","inchiKey":"RZXLPPRPEOUENN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORFENSON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorfenson"],"crossReferences":{"PubChem":["144208461","144213059"],"drugbank":["DB05377"],"chEBI":["82155"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL515564","canonicalSmiles":"CCCCCCCCCCCCCCCCOCCCOP(=O)(O)CO[C@H](C)Cn1cnc2c(N)ncnc21","inchiKey":"SCTJKHUUZLXJIP-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENOFOVIR EXALIDEX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CMX-157","CMX157","Cmx157","Hdp-tenofovir","Hexadecyloxypropyl Tenofovir","Tenofovir exalidex"],"crossReferences":{"drugbank":["DB14925"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL519504","canonicalSmiles":"CO[C@@H](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)c2ccsc12)C(=O)O","inchiKey":"DAYKLWSKQJBGCS-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALEGLITAZAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aleglitazar","R-1439","R1439","RO-0728804","RO0728804","Ro-0728804"],"crossReferences":{"Wikipedia":["Aleglitazar"],"drugbank":["DB08915"]},"linkedTargets":{"rows":["ENSG00000186951","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL523299","canonicalSmiles":"OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2.[Br-]","inchiKey":"PEJHHXHHNGORMP-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"UMECLIDINIUM BROMIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1187833","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Incruse ellipta"],"synonyms":["Anoro ellipta","GSK-573719A","GSK573719A","Umeclidinium brom","Umeclidinium bromide"],"crossReferences":{"DailyMed":["umeclidinium%20bromide"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000464","EFO_0006505","MONDO_0004979","EFO_0000341"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 4 approved and 1 investigational indication."}
{"id":"CHEMBL524266","canonicalSmiles":"Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1","inchiKey":"LCBAQTCTQXHTJG-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL524266","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07149"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL55612","canonicalSmiles":"CCC[C@H](N)C(=O)O","inchiKey":"SNDPXSYFESPGGJ-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORVALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Amino-Pentanoic Acid","L-Norvaline"],"crossReferences":{"Wikipedia":["Norvaline"],"drugbank":["DB04185"],"chEBI":["18314"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL66280","canonicalSmiles":"C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"NTXUAWGNGBSCRS-TZQXKBMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-IODO,5'-DEOXYTUBERCIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Iodo,5'-Deoxytubercidin"],"crossReferences":{"drugbank":["DB07173"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL698","canonicalSmiles":"CCCCNc1ccc(C(=O)OCCN(C)C)cc1","inchiKey":"GKCBAIGFKIBETG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRACAINE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ametop","Dicaine","Medihaler-tetracaine","Metraspray","Pontocaine"],"synonyms":["Amethocaine","Tetracaine"],"crossReferences":{"DailyMed":["tetracaine","tetracaine%20hydrochloride"],"PubChem":["11111916","11111917","50111267","90340576"],"Wikipedia":["Tetracaine"],"drugbank":["DB09085"],"chEBI":["9468"]},"childChemblIds":["CHEMBL1255654"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0009540","HP_0000989","EFO_1001178","MONDO_0041052","EFO_0000701","EFO_1001054","EFO_0003843","EFO_0000546","MONDO_0005301","HP_0030834","MONDO_0005129","EFO_0004143","EFO_0009552","EFO_1001887","EFO_1001434","MONDO_0005178"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 approved and 9 investigational indications."}
{"id":"CHEMBL710","canonicalSmiles":"CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"DBEPLOCGEIEOCV-WSBQPABSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FINASTERIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aindeem","Finasteride","Propecia","Proscar","Prostide"],"synonyms":["Finasteride","MK-906","NSC-741485","NSC-759318"],"crossReferences":{"DailyMed":["finasteride"],"PubChem":["144204268","144208704","144213061","170464818","26719811","26753508","26753509","49666458"],"Wikipedia":["Finasteride"],"drugbank":["DB01216"],"chEBI":["5062"]},"linkedTargets":{"rows":["ENSG00000277893"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","Orphanet_79364","EFO_0000673","EFO_0003839","EFO_0000284","EFO_0000536","EFO_0003894","EFO_0004191","MONDO_0008315","EFO_0003877","EFO_0001663","MONDO_0003037","EFO_0003060"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 6 approved and 6 investigational indications."}
{"id":"CHEMBL741","canonicalSmiles":"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1","inchiKey":"PYZRQGJRPPTADH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LAMOTRIGINE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lamictal","Lamictal cd","Lamictal odt","Lamictal xr","Lamotrigine"],"synonyms":["BW 430C","BW-430C","Lamotrigine","NSC-759171"],"crossReferences":{"DailyMed":["lamotrigine"],"PubChem":["11113342","144203730","170465024","174006315","26719658","50104089","56423136","85231112","855818","90341162"],"Wikipedia":["Lamotrigine"],"drugbank":["DB00555"],"chEBI":["6367"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0002610","EFO_1001219","MONDO_0041052","MONDO_0002009","HP_0000726","Orphanet_206656","HP_0100543","EFO_0004247","EFO_0000474","EFO_0000289","MONDO_0002050","EFO_0004263","EFO_0003100","EFO_1000632","EFO_0003761","MONDO_0007079","EFO_0005230","EFO_0008522","HP_0002069","EFO_0005203","EFO_0005039","HP_0012076","EFO_0000677","EFO_0009963","EFO_0003929","Orphanet_636","HP_0001250","Orphanet_2382","Orphanet_64280","EFO_0001073","EFO_0003843","EFO_0001072","EFO_0003890","Orphanet_79292","EFO_0000764","MONDO_0004979","EFO_0005611","EFO_0007262"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 10 approved and 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL753","canonicalSmiles":"CC(COc1ccccc1)N(CCCl)Cc1ccccc1","inchiKey":"QZVCTJOXCFMACW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOXYBENZAMINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bensylyt","Benzylyt","Dibenylin","Phenoxybenzamine"],"crossReferences":{"DailyMed":["phenoxybenzamine%20hydrochloride"],"PubChem":["104171113","124879342","124879343","144203638","170465147","174007411","26752309","26752310","90341231"],"Wikipedia":["Phenoxybenzamine"],"drugbank":["DB00925"],"chEBI":["8077"]},"childChemblIds":["CHEMBL1200787"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0005207","EFO_0000319","EFO_0000239"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for cardiovascular disease and adrenal gland pheochromocytoma and has 1 investigational indication."}
{"id":"CHEMBL87580","canonicalSmiles":"CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1","inchiKey":"DHNYNLNKNQJSHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL87580","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06883"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL930","canonicalSmiles":"NC(=O)CC[C@H](N)C(=O)O","inchiKey":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTAMINE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Endari","Nutrestore"],"synonyms":["FEMA NO. 3684","Glutamine","L-glutamine","Levoglutamide","NSC-27421"],"crossReferences":{"DailyMed":["l-glutamine"],"PubChem":["26747519","50106343","90341595"],"Wikipedia":["Glutamine"],"drugbank":["DB00130"],"chEBI":["18050"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for primary short bowel syndrome and sickle cell anemia and has 35 investigational indications."}
{"id":"CHEMBL93077","canonicalSmiles":"O=C(C[S+]([O-])C(c1ccccc1)c1ccccc1)NO","inchiKey":"CGNMLOKEMNBUAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADRAFINIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adrafinil","Olmifon"],"crossReferences":{"PubChem":["144205811","29217469","50111697"],"Wikipedia":["Adrafinil"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL96783","canonicalSmiles":"OC[C@H](O)[C@@H](O)[C@H](O)CO","inchiKey":"HEBKCHPVOIAQTA-SCDXWVJYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XYLITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-xylidex cr 16055","E-967","E967","Eutrit","Fluorette","INS NO.967","INS-967","Kannit","Klinit","Kylit","NSC-25283","Xylitab 300","Xylite","Xylite (sugar)","Xylitol","Xylitol cm 90","Xylitol, d-","Xyliton","Xylo-pentane-1,2,3,4,5-pentol","Xylo-pentitol"],"crossReferences":{"PubChem":["144208254"],"Wikipedia":["Xylitol"],"drugbank":["DB11195"],"chEBI":["17151"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
